Available in two sizes to fit most patients, helps physicians worldwide giving end-stage heart failure patients the priceless gift of more time.
The first and only commercially available replacement device, to full functions of a human heart. Provides a new heart without the wait for patients with end-stage heart failure affecting both sides of the heart (biventricular failure).
More than 2,000 implants in over 20 countries and strong clinical data.
Team at Baylor University Medical Center Dallas TX recently implanted and bridged a young woman to heart transplantation. Read More >
On the heels of the FDA approval of the new software updates for the Freedom Driver, SynCardia was out in force at the 2023 Annual Conference of the American Society of Artificial Internal Organs (ASAIO). Read More >
A preliminary proxy statement has been filed with the Securities and Exchange Commission by Altitude Acquisition Corp. for its proposed merger with Picard Medical, Inc and SynCardia Systems LLC. Read More >
Prolonging and Enabling High-Quality Lives
1992 E. Silverlake Rd. Tucson, AZ 85713
+1 520-545-1234 | firstname.lastname@example.org
The SynCardia Total Artificial Heart is a treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure.
Medical Advice Disclaimer
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or a qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read on this website.
© SynCardia Systems, LLC | All rights reserved.